ETFsBloomberg BioEnergy Screened Index
Amundi
Amundi Global Bioenergy UCITS ETF EUR Acc
CWE PAAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
545.30EUR
+0.39% · +€2.10
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
CWEBase
- Fund charges
- 0.35%Total expense ratio (TER)
- Fund size
- €155.7Mall share classes
- Return 1Y
- +50.0%
- Sharpe 3Y
- 0.64
- Volatility 1Y
- 18.2%annualised
- Holdings
- 28Fund holdings
Performance
Compare
- CWE+50.0%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| CWE | +1.6% | +6.9% | +15.3% | +51.5% | +50.0% | +49.5% | +108.6% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | +1.2% | +2.0% | +4.5% | +35.2% | +34.1% | -26.0% | +37.4% |
Risk and return
Sharpe ratio · 3Y
0.64
Below MSCI World · 1.24- Return p.a.
- +13.1%
- Volatility
- 17.2%
- Max loss
- -33.1%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CWE
0.64
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 70.4%
- Holdings
- 28
- As of
- 1HF SINCLAIR CORPUS40394910008.26%
- 2PHILLIPS 66US71854610407.89%
- 3VALERO ENERGY CORPORATIONUS91913Y10017.76%
- 4NOVONESIS (NOVOZYMES) BDK00603360147.54%
- 5ENI SPA MILANIT00031324767.51%
- 6UPM-KYMMENE OYJFI00090059876.63%
- 7ARCHER-DANIELS-MIDLAND COUS03948310206.59%
- 8VEOLIA ENVIRONNEMENTFR00001241416.44%
- 9NESTE OYJFI00090132965.90%
- 10BUNGE GLOBAL SACH13006462675.88%
Countries
Classified 99.6%
United States51.7%
Finland12.5%
FR
Denmark7.5%
Italy7.5%
DE
CA
- Largest
- 51.7%United States
- Top 3
- 73.8%
- Effective number
- 3.21 / HHI
Market cap
Weight vs holdings
70.4%of the fund sits in the top 10 holdings
70.4%29.2%
WeightHoldings
1018
- Holdings 1-10
- Holdings 11-28
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
